Newsletter "Life Science Newsletter (January 2025)" has been published.
Contents
1. Release of Summary Report on the Amendments to the Pharmaceuticals Act
1.1 Reinforcement of Quality Assurance and Safety Measures for Pharmaceuticals, etc.
1.2 Supply of Quality-Assured Ethical drugs, etc.
1.3 Improvement of Drug Discovery and Regulatory Environments to Eliminate Drug Lag and Drug Loss
1.4 Revision of Pharmacy Functions and Pharmacist Services and Promotion of Proper Use of Pharmaceuticals
2. NHI Price Revision for FY2025
To view the full article click here
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
